Back to search

Company profile

CASTLEREAGH PHARMACY LIMITED

active • ltd • 339 Castlereagh Road, Belfast, BT4 6AB

Company no.NI068372Officers7Documents20

Key company facts

Core operating details surfaced from the public profile endpoint.

Company Number
NI068372
Company Status
active
Type
ltd
Date Of Creation
2008-03-05
Registered Office
339 Castlereagh Road, Belfast, BT4 6AB
Sic Codes
other human health activities

Financials

A cleaner view of the latest filing, balance sheet movement, and multi-year trend.

Total assets

£1.21m

Equity

£1.06m

Total liabilities

£148,377

Cash in bank

£74,901

Year-on-year movement

Quick comparison from the latest filed period.

2025-04-30

Equity

+£39.85k

+3.91%

Cash in bank

-£16.30k

-17.87%

Total assets

-£17.80k

-1.45%

Total liabilities

+£57.65k

+27.98%

Financial trend

Multi-year view of the main balance sheet lines.

Net Assets
Total Assets
Total Liabilities
20212022202320242025

Latest snapshot

Financial year2025
Statement date2025-04-30
Trade debtors£0
Trade creditors£0
Fixed assets£215,440
Current assets£991,636
YearNet AssetsTotal AssetsTotal Liabilities
2021£805,514£1.21m-£406,027
2022£863,542£1.21m-£348,348
2023£892,037£1.17m-£278,825
2024£1.02m£1.22m-£206,029
2025£1.06m£1.21m-£148,377

Available In The Full Platform

Unlock deeper company intelligence

More company intelligence is available through your account, including premium data, deeper records, and advanced insight.

Locked contact intelligence

Contact Details & Ownership

Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.

Locked insight

Sign up or log in to view contact insight

Contact DetailsShareholdersGroup StructureCorporate Network Graph

Locked compliance screening

Risk & Compliance

Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.

Locked insight

Sign up or log in to access compliance insight

KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register

Locked financial insight

Financial Intelligence

Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.

Locked insight

Sign up or log in to unlock financial insight

AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges

Locked filing intelligence

Assets, Filings & Registers

Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.

Locked insight

Sign up or log in to explore filing insight

PropertyTrademarkGazette NoticesCharges

Latest activity

Recent company and officer updates, reshaped from the watchlist activity source for public profile use.

UpdateDateRecency
Confirmation Statement Submitted18 Mar 20262 Months
Accounts Submitted20 Jan 20264 Months
Confirmation Statement Submitted6 Mar 20251 Year
Accounts Submitted16 Jan 20251 Year
Confirmation Statement Submitted16 Jan 20251 Year
Change of Date Of Creation16 Jan 20251 Year
Change of Jurisdiction16 Jan 20251 Year
Change of Last Full Members List Date16 Jan 20251 Year
Change of Registered Office Address16 Jan 20251 Year
Change of Type16 Jan 20251 Year
CULLINAN, Teresa Appointed5 Mar 200818 Years
CULLINAN, Gerard Appointed5 Mar 200818 Years

Documents

Public filing documents and direct PDF links where available.

DescriptionDateDocument
change-to-a-person-with-significant-control2026-03-18Open PDF
change-to-a-person-with-significant-control2026-03-18Open PDF
confirmation-statement-with-updates2026-03-18Open PDF
change-person-director-company-with-change-date2026-03-18Open PDF
change-person-director-company-with-change-date2026-03-18Open PDF
accounts-with-accounts-type-unaudited-abridged2026-01-20Open PDF
confirmation-statement-with-updates2025-03-06Open PDF
accounts-with-accounts-type-unaudited-abridged2025-01-16Open PDF
confirmation-statement-with-updates2024-03-12Open PDF
change-person-director-company-with-change-date2024-03-12Open PDF
change-to-a-person-with-significant-control2024-03-12Open PDF
change-to-a-person-with-significant-control2024-03-12Open PDF